The Centers for Disease Control and Prevention (CDC) has loosened COVID-19 guidelines, citing “significantly less risk of severe illness, hospitalization and death.”

Researchers examined decades of data from more than 5,000 patients, sharing their findings in the Journal of the American Heart Association.

While current guidelines endorse screening for people aged 65 and above, a massive simulation published in JAMA Health Forum suggests that cost-effectiveness may extend to even younger age groups.

Upgrading to dual-source, dual-energy CT machines cut average pediatric scan times from around 12 seconds to three seconds or less at two sites of an academic emergency department.

“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.

Three recent NIH-supported studies took a close look at disparities in cardiovascular care.

In the study, patients who had recovered from an COVID infection were injected with a small amount of the 89Zr-labeled radiotracer before undergoing a uExplorer PET/CT scan.

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis.